aXichem
1.33 SEK
+2.71 %
Less than 1K followers
AXIC A
First North Stockholm
Chemicals
Basic Materials
Overview
Financials & Estimates
Ownership
Investor consensus
+2.71 %
-34.57 %
-35.52 %
-45.52 %
-46.83 %
-3.98 %
-89.61 %
-96.62 %
-92.10 %
aXichem is active in industrial biotechnology. The company develops, patents and markets industrial chemicals. The company works mainly with Phenylcapsaicin, a natural analogue synthetic capsaicin with applications in a variety of areas, such as in the marine sector, among pest control in forestry and agriculture, and among individual pharmaceutical work areas. Operations are conducted on a global level, with headquarters in Malmö.
Read moreMarket cap
89.52M SEK
Turnover
46.03K SEK
Revenue
8.57M
EBIT %
-184.71 %
P/E
-
Dividend yield-%
-
Revenue and EBIT-%
Revenue M
EBIT-% (adj.)
EPS and dividend
EPS (adj.)
Dividend %
Financial calendar
26/2
2026
Annual report '25
21/5
2026
Interim report Q1'26
17/6
2026
General meeting '26
All
Press releases
3rd party
ShowingAll content types
aXichem AB (publ), Year End Report, January - December 2025
aXichem AB: aXichems VD Torsten Helsing presenterar rapport för fjärde kvartalet 2025 i en direktsänd webbkonferens
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools